Sabine Brookman-May/X
Mar 22, 2025, 06:28
Sabine D. Brookman-May: What is the best strategy in BCG unresponsive HR NMIBC?
Sabine D. Brookman-May, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences, shared a post on X:
“What is the best strategy in BCG unresponsive HR NMIBC?
Carme Mir: one line salvage treatment + consider also initial response to BCG
Ashish M. Kamat: improved cysto + imaging + biomarkers are needed.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 25, 2025, 20:58
Aug 25, 2025, 20:44
Aug 25, 2025, 20:33
Aug 25, 2025, 19:54
Aug 25, 2025, 19:00
Aug 25, 2025, 17:36